IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

  • ID: 1408491
  • Report
  • Region: Norway
  • 45 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

Norway

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • National Insurance Scheme
  • Regulation & Provision

2. Pricing

  • Prescription Drugs
  • Applications
  • Timeline
  • Generic Drugs
  • Generics
  • Biosimilars
  • Hospital Drugs
  • LIS
  • Pricing Negotiations
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Admission to Reimbursement
  • Applications
  • Procedure
  • High-cost Drugs
  • Reimbursement Contracts
  • Timelines
  • Reimbursement Categories
  • Reimbursement Schedules
  • Reimbursement Prices
  • Stepped-price System
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • Hepatitis C Drugs
  • Changes in Reimbursement Prices
  • NoMA
  • Manufacturers

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • Role in Reimbursement Decisions
  • HTA System for Hospital Drugs

5. Price Build Up

  • Wholesalers
  • Margins
  • Background
  • Retail Pharmacies
  • Remuneration
  • Background
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Promotion
  • Advertising
  • Supervision
  • Patient Co-payments
  • Pharmaceuticals
  • Healthcare
  • Co-payment Ceilings
  • Prescribing Controls
  • Prescribing Budgets
  • Preferred Drug Guidelines
  • National Guidelines
  • Other Guidance
  • Prescription Monitoring
  • E-prescriptions
  • Generics
  • Substitution
  • INN Prescribing
  • Analogous Process Patents
  • Rx-to-OTC Switches
  • Parallel Trade

7. Future Developments

  • Outlook
  • Reimbursement Reform
  • H-resept
  • INN Prescribing
  • Pharmacy Remuneration

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll